Screening for Chlamydia trachomatis

BMJ 1998;316:1474-1480 ( 16 May )

Editorials

Screening for Chlamydia trachomatis

The case for screening is made, but much detail remains to be worked out

News p 1479

The first 150 words of the full text of this article appear below.

This month the chief medical officer of England published the report of an expert advisory group on Chlamydia trachomatis,which highlighted the need for immediate action to reduce theprevalence of chlamydia infection and the morbidity associatedwith it.¹ Chlamydia is the most prevalent, treatable sexuallytransmitted infection in the United Kingdom and has serious sequelae,including pelvic inflammatory disease, infertility, ectopic pregnancy,and neonatal infections. All these conditions, except for infertility,have been shown to be preventable if chlamydia trachomatis istreated in its asymptomatic phase. The expert group is proposingan education campaign to increase awareness of chlamydia infectioncoupled with opportunistic screening of asymptomatic sexuallyactive young women.

The advisory group's main recommendations are to offer testing to all men and women with symptoms of infection, all attendersat genitourinary medicine clinics, and women seeking terminationsof pregnancy and to screen opportunistically sexually active womenaged . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Article

Screening for Chlamydia trachomatis: I Simms, G Hughes, M Catchpole, C Thompson, Harisadhan Maiti, Heather Bower, Jenny Norrie, Margaret Polaneczky, and A A Opaneye
BMJ 1998 317: 680. [Extract] [Full Text]

This article has been cited by other articles:

van Bergen, J, Gotz, H M, Richardus, J H, Hoebe, C J P A, Broer, J, Coenen, A J T, for the PILOT CT study group, (2005). Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex. Transm. Infect. 81: 17-23 [Abstract] [Full text]
Low, N., Egger, M. (2002). What should we do about screening for genital chlamydia?. Int J Epidemiol 31: 891-893 [Full text]
de Sa, A. B., Gomes, J. P., Viegas, S., Ferreira, M. A., Paulino, A., Catry, M. d. A. (2002). Genital infection by Chlamydia trachomatis in Lisbon: prevalence and risk markers. Fam Pract 19: 362-364 [Abstract] [Full text]
Opaneye, A A, Bashford, J, Ashton, V (2002). A comparison of two methods for detection of Chlamydia trachomatis in the male urethra. The Journal of the Royal Society for the Promotion of Health 122: 58-60 [Abstract]
Pimenta, J., Catchpole, M., Gray, M., Hopwood, J., Randall, S. (2000). Evidence based health policy report: Screening for genital chlamydial infection. BMJ 321: 629-631 [Full text]
Duncan, B., Hart, G. (1999). Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ 318: 931-933 [Full text]
Taylor-Robinson, D., Robinson, A. J (1998). DNA methods should be used to detect Chlamydia trachomatis. BMJ 317: 1525-1525 [Full text]
Simms, I, Hughes, G, Catchpole, M (1998). Screening for Chlamydia trachomatis. BMJ 317: 680a-680 [Full text]

Rapid Responses:

Read all Rapid Responses

Expanding Chlamydia Screening Beyond the Doctor's Office: Margaret Polaneczky
bmj.com, 18 May 1998 [Full text]
Chlamydia Screening and Treatment demand commitment: A A Opaneye
bmj.com, 21 May 1998 [Full text]
Contact tracing for chlamydial infections: C Thompson
bmj.com, 10 Jun 1998 [Full text]
Chlamydia trachomatis, screening the men: B Stanley
bmj.com, 15 Jun 1998 [Full text]
Tests for Chlamydia trachomatis in the Genitourinary Medicine service: Angela Robinson
bmj.com, 25 Aug 1998 [Full text]